Clinical study on Omeprazole in prevention of acute pancreatitis induced by endoscopic retrograde choledo-chopancreatography
- VernacularTitle:奥美拉唑预防逆行胰胆管造影术后急性胰腺炎的临床研究
- Author:
Jinqi WEI
;
Weihu LU
;
Zhuang BIAN
;
Yuping TIE
;
Lihua ZHANG
- Publication Type:Journal Article
- Keywords:
Acute pancreatitis;
Omeprazole;
Endoscopic retrograde choledochopancreatography;
Hy-peramyLasemia
- From:
Clinical Medicine of China
2008;24(10):1049-1051
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the preventive effect of Omeprazole on post-endoscopic retrograde choledo-chopallcreatography(ERCP)-induced pancreatitis.Methods 126 patients were divided into two groups at random.One group received Omeprazole 20mg bid for two days.and the other group received placebo(Vitamine B).Blood was drawn in each group the day before,4 hours and 24 hours following ERCP for examination of amylase and hepa-torenal functions.Meanwhile Meanwhile the clinical manifestations of acute pancreatitis were also observed.Results Acute pancreatitis was clinically induced in 1.59% cases of placebo group,but none in the Omeprazole group.Hyperamy-lasemia occurred in 20.63%-7.93%in Omeprazole group at 4 hours and 24 hours after ERCP operation,while 30.16%.14.29%in placebo group;The incidence rate of acute pancreatitis following ERCP and hyperamylasemia 4 h after ERCP in omeprazole group were significantly lower than in placebo group(P<0.01,P<0.05).There were no significance differences in amylase 24 hours following ERCP between two groups(P>0.05).Concluslon Omeprazole can prevent the acute pancreatitis induced by ERCP to some extent.
